DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs

Information source: NIH AIDS Clinical Trials Information Service
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: HIV Infections

Intervention: Efavirenz (Drug); Emtricitabine (Drug); Stavudine (Drug); Didanosine (Drug)

Phase: Phase 3

Status: Active, not recruiting

Sponsored by: Triangle Pharmaceuticals

Summary

The purpose of this study is to compare the safety and effectiveness of emtricitabine and stavudine when given with didanosine plus efavirenz to HIV-infected patients.

Clinical Details

Official title: A Randomized, Double-Blind, Equivalence Trial Comparing Emtricitabine to Stavudine Within a Triple Drug Combination Containing Didanosine Plus Efavirenz in Antiretroviral-Drug Naive HIV-1 Infected Patients

Study design: Treatment, Double-Blind, Safety Study

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria

Patients may be eligible for this study if they:

- Are at least 18 years old at the time of screening.

- Have plasma HIV-1 RNA loads (level of HIV in your blood) of 5,000 or more copies/ml at

the time of screening.

- Have not used any anti-HIV therapy for more than 2 days.

- Have a negative pregnancy test within 22 days of starting study drugs.

- Can be reached by telephone.

Exclusion Criteria

Patients will not be eligible for this study if they:

- Are pregnant or breast-feeding.

- Use alcohol or illegal drugs that, in the opinion of the principal investigator, may

interfere with the patient's ability to follow the dosing schedule and protocol evaluations.

- Are being treated for active tuberculosis.

- Are using astemizole, cisapride, midazolam, triazolam, ergot derivatives, St. John's

wort, or drugs for a mental disorder.

- Have a history of a serious mental disorder.

- Are unwilling to use an effective barrier method of birth control during the study

(for women who can get pregnant).

- Have a history of opportunistic infections and cancers (Mycobacterium avium complex,

cytomegalovirus, toxoplasmic encephalitis or disseminated toxoplasmosis, cryptosporidiosis, Isospora belli, progressive multifocal leukoencephalopathy, visceral Kaposi's sarcoma, and lymphoma). Patients with past episode of pulmonary tuberculosis, Pneumocystis carinii pneumonia, or isolated cutaneous Kaposi's sarcoma are allowed. Medication for the prevention of PCP (TMP/SMX, nebulized pentamidine, and atovaquone) is allowed.

- Have peripheral neuropathy (a painful condition affecting the nervous system) or

history of peripheral neuropathy.

- Cannot take medicine by mouth or have severe chronic diarrhea within 30 days before

beginning the study.

- Cannot eat 1 or more meals a day because of chronic nausea, vomiting, or abdominal or

esophageal discomfort.

- Have had a serious illness or injury within 30 days of screening. Treatment must have

been completed for 14 days prior to study entry.

- Have a history of AIDS-defining opportunistic infection, except for tuberculosis or

infection of the stomach or intestines.

Locations and Contacts

FUNCEI, Buenos Aires, Argentina

Fundacion HUES, Buenos Aires, Argentina

Hospital de Agudos JM Ramos Mejia, Buenos Aires, Argentina

Hospital Muniz, Buenos Aires, Argentina

Hospital Interzonal Gen de Agudos Oscar Alende, Mar del Plata, Argentina

Fundacion Arriaran, Santiago, Chile

Instituto Nacional de la Nutricion, Mexico City, Mexico

San Juan Veterans Administration Med Ctr, San Juan 009275800, Puerto Rico

Univ of Alabama at Birmingham, Birmingham, Alabama 352942050, United States

Viridae Clinical Sciences / University of British Columbia, Vancouver, British Columbia, Canada

Saint Francis Mem Hosp / HIV Care, San Francisco, California 94109, United States

St Lukes Medical Group, San Diego, California 92101, United States

Davies Med Ctr, San Francisco, California 94114, United States

Mem Med Group Inc, Long Beach, California 90806, United States

AIDS Healthcare Foundation, Los Angeles, California 90027, United States

East Bay AIDS Ctr, Berkeley, California 94705, United States

Orange Coast Med Group, Newport Beach, California 92663, United States

Robert Smith Medical Group, San Diego, California 92103, United States

East Bay Clinical Trial Ctr, Concord, California 94520, United States

Univ of Colorado Health Ctr / Denver Gen Hosp, Denver, Colorado 80262, United States

Beacon Clinic / Boulder Community Hosp, Boulder, Colorado 80304, United States

Blick Med Associates, Stamford, Connecticut 06901, United States

George Washington Univ Med Ctr, Washington, District of Columbia 20037, United States

Physicans Home Service, Washington, District of Columbia 20037, United States

South Miami Hosp, Miami, Florida 33143, United States

Gary Richmond MD, Fort Lauderdale, Florida 33316, United States

Health Positive, Safety Harbor, Florida 34695, United States

Infectious Diseases Associates, Sarasota, Florida 34239, United States

Hillsborough County Health Department, Tampa, Florida 33602, United States

Larry Bush, Palm Springs, Florida 33461, United States

Infectious Disease Research Inst, Tampa, Florida 33614, United States

Wohlfeiler, Piperator & King, MD, PA, Miami Beach, Florida 33139, United States

Ingenix Kern McNeill Decatur, Atlanta, Georgia 30309, United States

Infectious Disease Specialists of Atlanta, Decatur, Georgia 30033, United States

Harbin Clinic, Rome, Georgia 30165, United States

Northstar Med Clinic, Chicago, Illinois 60657, United States

Tulane Univ Med Ctr / Infectious Diseases Sect, New Orleans, Louisiana 70112, United States

Institute of Human Virology, Baltimore, Maryland 21201, United States

New England Med Ctr, Boston, Massachusetts 02111, United States

Fenway Community Health Ctr, Boston, Massachusetts 02115, United States

Abbott-Northwestern Hosp / Clinic 42, Minneapolis, Minnesota 55404, United States

South Jersey Infectious Diseases Inc, Somers Point, New Jersey 08244, United States

Albert Einstein College of Medicine, Bronx, New York 10461, United States

Erie County Med Ctr, Buffalo, New York 14215, United States

North Shore Univ Hosp / Div of Infectious Diseases, Manhasset, New York 11030, United States

Mount Sinai School of Medicine, New York, New York 10029, United States

Howard Grossman, New York, New York 10011, United States

Liberty Medical / Cabrini Hospital / Dept of Infec Diseases, New York, New York 10003, United States

Dr Lawrence Fontana, New York, New York 10003, United States

McMaster Univ Med Centre, Hamilton, Ontario, Canada

Fanno Creek Clinic, Portland, Oregon 97219, United States

Centre De Recherche En Infectiologie, Ste Foy, Quebec, Canada

Montreal Gen Hosp, Montreal, Quebec, Canada

Paragon Clinical Research, Cranston, Rhode Island 02920, United States

Coastal Carolina Research Ctr, Mount Pleasant, South Carolina 29464, United States

Univ TX Galveston Med Branch, Galveston, Texas 77555, United States

Houston Clinical Research Network, Houston, Texas 77006, United States

Walter Gaman, Irving, Texas 75038, United States

Nelson Tebedo Health Resource Ctr, Dallas, Texas 75219, United States

Diversified Med Practices, PA, Houston, Texas 77027, United States

Amelia Ct Clinic, Dallas, Texas 75235, United States

Central Texas Clinical Research, Austin, Texas 78705, United States

Swedish Med Ctr / Dr Peter Shalit, Seattle, Washington 98104, United States

Additional Information

Starting date: August 2000
Last updated: June 23, 2005

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009